Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Clinical trial NCT03709446 · COMPLETED

Trial details

NCT number: NCT03709446
Sponsor: Joseph Sparano
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Breast Diseases Metastatic Triple Negative Breast Cancer

Start date: 2019-04-16
Primary completion: 2025-11-27
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.